AZ plots wider Imfinzi use in bladder cancer after trial win

AZ plots wider Imfinzi use in bladder cancer after trial win

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in early bladder cancer

Imfinzi Regimen Improves Disease-Free Survival in Early Bladder Cancer

Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for some with bladder cancer.

AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China

Plus, news about Sanofi, IGM Biosciences, Eli Lilly, Purdue University, Minghui, Qilu, Sirius Therapeutics, Keros Therapeutics, Palatin and Leo Pharma: 💉AstraZeneca touts Imfinzi Phase 3 win in high-risk bladder cancer: The company’s